INTELLIA THERAPEUTICS
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments. It can positively transform the lives of people living with severe and life-threatening diseases. IIntellia holds exclusive access to one of the most comprehensive intellectual property platforms available for the therapeutic use of CRISPR-Cas9. The company is advancing a broad pipeline toward clinical development, including ex Vivo, and in vivo approaches. Intellia Therapeutics was formed in 2014 and is headquartered in Cambridge, Massachusetts.
INTELLIA THERAPEUTICS
Industry:
Biotechnology Genetics Health Care Medical Therapeutics
Founded:
2014-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.intelliatx.com
Total Employee:
251+
Status:
Active
Contact:
(857) 285-6200
Email Addresses:
[email protected]
Total Funding:
775 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
2seventy bio
2seventy bio is an immuno-oncology cell therapy company that discovers and develops therapies used for cancer treatment.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Chroma Medicine
Chroma Medicine is a new genomic medicine company working on epigenetic editing.
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-02-03 | Rewrite Therapeutics | Rewrite Therapeutics acquired by Intellia Therapeutics | N/A |
Investors List
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series B - Intellia Therapeutics
Janus Capital Group
Janus Capital Group investment in Series B - Intellia Therapeutics
Sectoral Asset Management
Sectoral Asset Management investment in Series B - Intellia Therapeutics
EcoR1 Capital
EcoR1 Capital investment in Series B - Intellia Therapeutics
Foresite Capital
Foresite Capital investment in Series B - Intellia Therapeutics
Atlas Venture
Atlas Venture investment in Series B - Intellia Therapeutics
OrbiMed
OrbiMed investment in Series B - Intellia Therapeutics
Novartis
Novartis investment in Series B - Intellia Therapeutics
Caribou Biosciences
Caribou Biosciences investment in Series A - Intellia Therapeutics
Novartis
Novartis investment in Series A - Intellia Therapeutics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-01-26 | Kyverna Therapeutics | Intellia Therapeutics investment in Series B - Kyverna Therapeutics | 85 M USD |
| 2021-10-13 | SparingVision | Intellia Therapeutics investment in Corporate Round - SparingVision | N/A |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-16 | Orna Therapeutics Expands Leadership Team with Key Executive Hires |
| 2020-04-30 | Intellia Therapeutics Taps Semma’s Lebwohl as Chief Medical Officer |
Official Site Inspections
http://www.intelliatx.com Semrush global rank: 1.26 M Semrush visits lastest month: 23.7 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Intellia Therapeutics"
About - Intellia Therapeutics
Our leaders bring all the necessary skills and experience from world-leading organizations and embody Intellia’s values — one, explore, disrupt, deliver — to deliver gene editing Also called …See details»
Intellia Therapeutics - Crunchbase Company Profile & Funding
Organization. Intellia Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone …See details»
Intellia Therapeutics Highlights its Three-Year Strategic Priorities ...
Appointment as Chief Executive Officer of the Biotechnology Innovation Organization (BIO), the life sciences industry s ... Learn more at intelliatx.com and follow us @intelliatx . Forward …See details»
Intellia Therapeutics Company Profile | Management and
SQL International Organization for Standardization . C++ ISO/IEC JTC1/SC22/WG21 - The C++ Standards Committee . Python Python Software Foundation . ... [email protected]: Intellia …See details»
Vice President of Commercial Operations - Intellia Therapeutics
Manage the annual budget for the Commercial Operations organization. Perform other duties as assigned. About You: Minimum of 10 years of relevant experience, with a deep understanding …See details»
intelliatx.com - Whois.com
May 23, 2014 Whois Lookup for intelliatx.com. Login Sign up My Account Logout; Domains. Registration ... Registration Private Registrant Organization: Domains By Proxy, LLC …See details»
Intellia Therapeutics - SEC Filing
July 2014 and the former holder of all of our outstanding shares of stock. Our principal executive office is located at 130 Brookline Street, Suite 201, Cambridge, MA 02139, and our telephone …See details»
Intellia Therapeutics Announces Fourth Quarter and Full-Year 2020 ...
Feb 25, 2021 This increase was primarily driven by the advancement of our lead programs, research personnel growth to support these programs and expansion of the development …See details»
Intellia Therapeutics, Inc.: Culture | LinkedIn
Intellia Therapeutics, Inc. | 57,790 followers on LinkedIn. Developing curative genome editing treatments | Intellia Therapeutics is a leading genome editing company whose mission is to …See details»
Working At Intellia Therapeutics: Company Overview and Culture
Mar 14, 2024 www.intelliatx.com. Organization Type. Public. Social Media. Intellia Therapeutics was formed in 2014 to lead the industry in one of the most promising new areas of therapeutic …See details»
Associate Director, Corporate Analytics & Decision Support
Why Join Intellia? Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases. Beyond …See details»
Intellia Therapeutics Announces Fourth Quarter and Full-Year 2021 ...
This increase was primarily driven by the advancement of our lead programs, research personnel growth to support these programs and expansion of the development organization. G&A …See details»
Intellia Therapeutics Highlights its Three-Year Strategic Priorities ...
Jan 4, 2024 NTLA-2001 for ATTR Amyloidosis: Dose the first patient in MAGNITUDE trial of NTLA-2001 for the treatment of ATTR-CM in Q1 2024. Continue to open new sites and enroll …See details»
Intellia Therapeutics Names Glenn Goddard as New Chief Financial ...
Oct 29, 2018 [email protected]. Lynnea Olivarez Associate Director External Affairs & Communications +1 956-330-1917 [email protected]. Investors: Lindsey Trickett …See details»
Terms of Use - Intellia Therapeutics
However, Intellia is an organization committed to the highest professional standards. Therefore, Intellia does not grant any license or other permission for links or other use of the Website or …See details»
Intellia Therapeutics (@intelliatx) • Instagram photos and videos
See our website for details: www.intelliatx.com #CRISPR #GeneEditing. We’ve arrived at the @american_heart Scientific Sessions! #aha2024 #oneintellia. Intellia is gearing up for the …See details»
Intellia Therapeutics Announces First Quarter 2020 Financial Results
May 7, 2020 This increase was primarily driven by the advancement of our lead programs, research personnel growth to support these programs, as well as the expansion of the …See details»
Why Intellia is a ‘Top Place to Work’ – Intellia Therapeutics
Dec 1, 2022 That change-the-world mentality doesn’t just apply to our science. It applies to everything, which is what makes our culture vibrant and unique, not to mention, having …See details»
Frank Verwiel, M.D. - Board Member - Intellia Therapeutics
Previously, he served on the board of directors of the Biotechnology Industry Organization. Frank possesses significant biotech and pharmaceutical experience, having been the President and …See details»